How is anaemia treated in chronic kidney disease?

Just In
An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

According to the National Institute of Diabetes and Digestive and Kidney Disorders, the first line of treatment of anaemia in the cases of Chronic Kidney Disease (CKD) is treating any underlying conditions that may be causing the anaemia, such as an iron or vitamin deficiency. If your anaemia is mild and you have few symptoms, you may not need treatment at first. It may ease your symptoms and improve your quality of life.

You may be prescribed an Erythropoiesis-stimulating agent (ESA) to treat your anaemia. ESAs signal your bone marrow to make more red blood cells. If you’re on hemodialysis, you may receive IV or subcutaneous ESAs during your dialysis treatments. If you are on peritoneal dialysis or do not receive dialysis, your health care professional may give ESAs as shots. Sometimes, blood transfusions are given to treat severe anaemia in CKD.

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

History
First published on:

More in

Questions
Fact Check
Interviews
Stories
Videos
An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

More in

Questions
Fact Check
Interviews
Stories
Videos
An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

An iron or vitamin deficit must typically be treated in order to manage anemia in people with chronic kidney disease (CKD). Its medical therapy involves the use of erythropoiesis-stimulating agent that could be administered in the intravenous or subcutaneous form for those receiving hemodialysis. Further, ESA shots could be used for those receiving peritoneal dialysis, and severe anemia could be dealt with blood transfusions.

Last Updated on August 16, 2022 by Dr. Saumya Saluja

Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

- Advertisement -spot_img
Dr. Shikha Shiromani
Dr. Shikha Shiromani
A dental surgeon by education and medical writer by profession, Shikha is responsible for research and fact-check.
Read More